STOCKS NEWS US-Glaxo ADRs fall after signing deuterium drug deal

Stocks on the move [HOT-RTRS]

Real-time Equity news [U E] [RESF/US]

For U.S. stock market report double-click [.N] 0857 ET 02June2009-Glaxo ADRs fall after signing drug deal ------------------------------------------------------------------------------

U.S.-listed shares of GlaxoSmithKline (GSK.N) fell in premarket trading on Tuesday after the pharmaceutical company signed a potential $1 billion deal with privately-held U.S. biotech company Concert Pharmaceuticals to access deuterium-containing medicines.

In the deal, Glaxo gets rights to three Concert research programs -- a protease inhibitor for HIV due to start Phase I clinical trials this year, a preclinical drug for chronic kidney disease and a third, unspecified product.

For details, see [ID:nL2533041]

Glaxo shares slid 1.8 percent to $33.58 before the bell on the New York Stock Exchange.

Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net 0844 ET 02June2009-More confidence may lessen interests in gov plans ------------------------------------------------------------------------------

U.S. Treasury Secretary Timothy Geithner on Tuesday said that improving confidence in the economy may lessen banks' interest in government-designed programs to reduce toxic assets from bank balance sheets.